Miguel López‐Botet
About
In The Last Decade
Miguel López‐Botet
189 papers receiving 12.3k citations
Hit Papers
Peers
Comparison fields: 5 of 111
- Immunology 11.1k
- Oncology 2.4k
- Epidemiology 2.3k
- Molecular Biology 931
- Hematology 826
Countries citing papers authored by Miguel López‐Botet
This map shows the geographic impact of Miguel López‐Botet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miguel López‐Botet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miguel López‐Botet more than expected).
Fields of papers citing papers by Miguel López‐Botet
This network shows the impact of papers produced by Miguel López‐Botet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miguel López‐Botet. The network helps show where Miguel López‐Botet may publish in the future.
Co-authorship network of co-authors of Miguel López‐Botet
This figure shows the co-authorship network connecting the top 25 collaborators of Miguel López‐Botet. A scholar is included among the top collaborators of Miguel López‐Botet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miguel López‐Botet. Miguel López‐Botet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 16 | |
| 4 | 6 | |
| 5 | 3 | |
| 6 | 9 | |
| 7 | 13 | |
| 8 | 8 | |
| 9 | 19 | |
| 10 | 12 | |
| 11 | 26 | |
| 12 | 61 | |
| 13 | 53 | |
| 14 | 91 | |
| 15 | 61 | |
| 16 | 50 | |
| 17 | 54 | |
| 18 | Expression of a gp33/27,000 MW activation inducer molecule (AIM) on human lymphoid tissues. Induction of cell proliferation on thymocytes and B lymphocytes by anti-AIM antibodies. | 42 |
| 19 | Selective T cell subset depletion with anti-CD4 and anti-CD8 intact ricin immunotoxins. | 6 |
| 20 | 107 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.